Looking for a Cheaper mabl Alternative? Here's What I'd Compare Before Renewing

I have a fairly uncontroversial opinion that still seems to annoy people in software procurement: a good product can be a bad purchase.

That's where I put mabl for a particular kind of team.

It's a legitimate test automation platform. Its browser recorder is approachable, its automatic healing can save maintenance time, and the product extends well beyond clicking around a web page. It offers API, accessibility, performance, visual, email, and PDF testing. More recently, mabl has invested heavily in AI-assisted test authoring and recovery.

The problem isn't that mabl doesn't do enough. The problem is that you might be paying for a much larger testing platform than you actually need.

If I were reviewing a mabl renewal today, Endtest would be near the top of my shortlist. Not because it has a flashier AI pitch. Because it offers much of the test automation functionality most teams buy mabl for, with published entry pricing that's easier to budget for.

But you shouldn't switch testing platforms because of a blog post. You should switch because the numbers and the test results work out.

The expensive part isn't always the subscription

Think about an engineering team with eight developers, two QA engineers, and a SaaS product that ships every weekday.

They probably want five fairly ordinary things:

1. Someone should be able to create a browser test without spending an afternoon writing selectors.
2. Tests should run in CI and on a schedule.
3. When a test fails, the team should be able to tell whether the application is broken or the test is broken.
4. Important flows should run on more than one browser.
5. Adding coverage shouldn't mean hiring another automation engineer.

That's not a modest list. But it isn't especially exotic, either.

The subscription line on the budget is only the start. The real cost of testing includes people debugging failures, rewriting tests after UI changes, maintaining environments, and waiting for results. A cheaper tool that wastes three hours a week isn't cheaper for very long.

This is why I don't think a price-only comparison is useful. And it's also why mabl deserves credit: its automatic waits, healing, and reporting address real operational costs.

First, understand what you're paying for

mabl's pricing page currently directs buyers to request a custom quote. It describes a credit-based approach for cloud testing, beginning with 500 credits per month, alongside unlimited local runs and cloud concurrency at no additional concurrency charge. The exact economics depend on your contract and usage.

Endtest publishes a Starter plan at $175/month and a Pro plan at $450/month, plus custom enterprise pricing. Its pricing page lists unlimited test creation, executions, and users, with limits and entitlements that vary by plan, including parallel slots and AI features.

Those aren't directly comparable billing models. Don't confuse an unlimited-executions line with unlimited simultaneous capacity. And don't treat a credit as equivalent to an Endtest execution.

Still, published pricing gives you something useful: a concrete starting point for a negotiation or pilot.

Here's how I'd model it.

For example, if your mabl quote is $1,500 per month and the $450 Endtest configuration covers the same workload, the arithmetic is $18,000 versus $5,400 annually. That's a 70% reduction in subscription cost, or $12,600 per year.

That's a scenario, not an estimate of what mabl charges every customer. Your real quote might be higher or lower; you might also need more Endtest parallel capacity or an enterprise arrangement.

That distinction matters. An apparently cheap replacement isn't a bargain if you discover the missing requirement after migration.

Feature parity is the wrong question

People love feature grids. I understand why. They're easy to forward to a manager.

But the question, "Does Endtest have everything mabl has?" is too broad to be useful. Modern testing products change quickly, and both vendors have capabilities that may not map neatly onto the other's offering.

A better question is: Can the replacement execute our critical workflows, with the controls and evidence our team needs?

Here's the shortlist I'd start with:

For mabl's own capability breakdown, see its product overview. For Endtest, see its feature and plan breakdown.

Notice the last two rows. I would not claim blanket feature parity. mabl has an integrated performance-testing offering, and that could be a deciding factor if your QA team relies on it. Conversely, Endtest has capabilities such as browser-based recording, AI-driven test creation, and advanced browser execution options that may be more than sufficient for teams primarily focused on end-to-end regression testing.

A spreadsheet doesn't make that judgment. A trial does.

The test that tells me more than a sales demo

Don't build a demo around the login form. Both tools should pass it, and neither should get much credit for doing so.

Take a workflow that's been mildly irritating your team for the past year. Something like:

• Sign up with a new email address.
• Open the verification email and follow the link.
• Create a project.
• Upload a PDF to that project.
• Open a details panel embedded in an iframe.
• Edit a setting and confirm the result persists after a refresh.
• Assert that the expected record exists through an API call.

It's a better test than a pretty dashboard because it forces the product to deal with state, email, files, frames, and assertions. It also exposes whether the test output is something an engineer can inspect and fix.

I'd put the same workflow into both tools and score it on four things:

Coverage: How much can the tool do without custom code or brittle workarounds?

Creation time: How long until the test genuinely works, including assertions, not just until it looks plausible in an editor?

Repeatability: Does it survive repeated cloud runs, including after a small UI change?

Failure diagnosis: When it breaks intentionally, can an engineer locate the problem quickly?

A test that passes once tells you very little. A test that fails clearly is often more valuable.

A small experiment worth running

Here's a simple benchmark sheet I would use in a proof of concept. It takes less than a minute to understand and avoids the usual vendor-demo theater.

Run each scenario at least 20 times on each platform, using the same application version, data setup, and comparable execution environments.

A lightweight script can summarize the results from a CSV file exported or assembled from your run logs:

import csv
from collections import defaultdict
from statistics import median

# benchmark.csv columns:
# tool,scenario,passed,duration_seconds,debug_minutes
# passed must be 1 for a successful run, 0 otherwise.

runs = defaultdict(list)

with open("benchmark.csv", newline="", encoding="utf-8") as file:
    for row in csv.DictReader(file):
        runs[row["tool"]].append(row)

for tool, records in sorted(runs.items()):
    successes = sum(int(r["passed"]) for r in records)
    durations = [float(r["duration_seconds"]) for r in records]
    debugging = [float(r["debug_minutes"]) for r in records
                 if r["debug_minutes"].strip()]

    print(f"\n{tool}")
    print(f"  Stable-run rate: {successes / len(records):.1%}")
    print(f"  Median runtime: {median(durations):.1f}s")
    if debugging:
        print(f"  Median debug time: {median(debugging):.1f} min")

Keep failed-run durations in the runtime calculation, or report successful and failed runtimes separately. Otherwise a tool that fails quickly can look deceptively fast. Also record the root cause of every failure. A legitimate application bug is not an automation flake.

Most importantly, don't cherry-pick the best run of each tool. That's how you end up with an impressive benchmark and an unhappy engineering team.

Migrating is where the savings can disappear

Even if Endtest wins a proof of concept, I wouldn't immediately rewrite 400 existing tests.

I'd use a staged migration:

Week one: Inventory the suite. Identify critical user journeys, duplicate tests, long-running tests, flaky tests, and the features that require custom JavaScript or unusual integrations.

Week two: Rebuild a small but representative group in Endtest. Include one straightforward flow and several deliberately ugly ones. Run them in parallel with mabl against the same staging release.

Week three: Compare failures and operating effort. Track who diagnosed each failure, how long it took, whether an assertion was too weak, and whether your CI pipeline received a reliable pass/fail signal.

Week four: Decide what to migrate, what to retire, and what should stay where it is. Some tests may not be worth porting at all.

Your goal isn't to reproduce the historical test count. Your goal is to preserve useful coverage.

Migrating from other tools to Endtest is fairly easy, since you can just use their AI Test Import feature.

Where I'd still choose mabl

There are sensible reasons to stay.

If your team uses mabl's integrated performance testing, relies on its existing workflows across several departments, or has years of working tests with very little maintenance overhead, switching may be a distraction. Procurement friction and migration risk are real costs.

And mabl's unlimited local runs and cloud concurrency model might be particularly attractive at your usage level. Don't assume the lowest published competitor price will be the cheapest configuration for a large suite.

I'd also be cautious about any vendor, including Endtest, that promises AI will eliminate test maintenance. It won't. Your application still changes, your data still expires, and your test oracles still need to be correct.

AI can reduce the labor. It doesn't remove responsibility.

Where Endtest becomes hard to ignore

Now consider the more common case: a small or midsize engineering team mostly needs dependable end-to-end web testing, mobile coverage, API checks, cross-browser execution, and reasonable failure reports.

They don't have a dedicated automation-infrastructure team. They don't want to build their own browser grid. And every year somebody has to explain the QA tooling bill to finance.

For that team, Endtest is a serious alternative. You get an AI-enabled, no-code testing platform with substantial overlap in the workflows that drive a typical regression suite. You can inspect its pricing without starting with a sales call, and you can use a trial to find out whether its capabilities fit your application.

The cost difference can be substantial when your actual mabl quote is well above the Endtest plan that meets your needs. But that's something to establish with your own quote and your own tests, not a percentage copied from somebody else's benchmark.

One other useful question to ask before signing: If we cancel in two years, how easily can we take our test definitions and results with us? Data portability isn't exciting when you're buying a tool. It matters a great deal when you're replacing one.

The decision I'd make

I wouldn't recommend dumping mabl because it's a bad product. I don't think it is.

I'd recommend questioning whether it's the right-sized product for the job, especially if the next renewal is forcing your team to choose between broader test coverage and the budget to build actual product features.

Give Endtest the same hard scenarios. Compare creation time, real pass rates, debugging overhead, and the total annual bill. If it delivers the same useful coverage for your application at a fraction of the cost, the decision becomes pretty straightforward.

And if it doesn't, you've spent a few days validating that your mabl subscription is earning its keep.

Either way, you've replaced a sales argument with an engineering decision. That's a worthwhile result.